Join a Network of Clinicians Advancing Neuroimmune Medicine

CME-accredited education, expert case discussions, and a professional network focused on neuroimmune and inflammatory brain disorders.
Members include clinicians from leading academic medical centers and private practices worldwide.

Following payment, you will receive an email with login information within three business days.

Why Join The Neuroimmune Clinician Network

The Neuroimmune Clinician Network is designed for clinicians treating patients with complex conditions including PANS, PANDAS, inflammatory brain disorders, autoimmune encephalitis, seronegative encephalitis, and immune-mediated neurospsychiatric deteriorations including those occurring in patients with autism.

Neuroimmune Clinician Network members receive:

  • Live discussions and Q&As with highly regarded experts in the field
  • Access to a library of past CME lectures
  • Discounts to the Inflammatory Brain Disorders Conference
  • Curated research updates on inflammatory brain disorders
  • A resource relied upon by clinicians across academic and community healthcare settings worldwide

Inflammatory Brain Disorders Conference 2027

Neuroimmune Clinician Network Members 2027 Conference registration is reduced to $299 through 11/27/26. (Normally $899)

Please note that those wishing to purchase recording access for two months post-conference can do so for an additional $100 though CME is available just for those in live virtual attendance. You must maintain your membership through the conference to be eligible for the discounted member rates. Please read the TOS prior to purchase. Do not pay a rate other than what you are expecting as there are no refunds, partial or otherwise.

Learn From Leading Experts in Neuroimmune Medicine

Topics include: neuroinflammation, PANS/PANDAS, encephalitis, immunotherapy in psychiatric illness, autism, microbiome, and more. These live Q&As and webinars are open to members only. There is no fee for members to attend but registration is required.

Russell Dale, MBChB, PhD
(click photo for biography)

Q&A – September 29, 2026

3:00 pm PT/5 CT/6 ET

Focus: PANS/PANDAS, AE, seronegative encephalitis

Jennifer Frankovich, MD
(click photo for biography)

Q&A – Nov. 3, 2026

4:00 pm PT/6 CT/7 ET

Focus: PANS/PANDAS, Rheumatological Conditions

Kevin J. Tracey, MD
(click photo for biography)

Webinar – January 7, 2027

2:00 pm PT/4 CT/5 ET

Vagus Nerve Stimulation and Neuroimmunology

Jennifer Frankovich, MD
(click photo for biography)

Q&A – February 2, 2027

4:00 pm PT/6 CT/7 ET

Focus: PANS/PANDAS, Rheumatological Conditions

  • Questions are compiled 24 hours prior to each Q&A though you may submit questions via the Zoom Q&A button during the event (priority is given to questions submitted at the time of registration via Zoom).
  • Please note that panelists cannot give medical advice. By participating you agree you understand you are not receiving medical advice but rather insight as to how patients in their cohort have responded to various treatments.
  • Please do not ask patient specific questions.

The Neuroimmune Clinician Network is designed for researchers and clinicians treating patients with complex conditions including PANS, PANDAS, inflammatory brain disorders, encephalitis, and immune-mediated neuropsychiatric deteriorations, including those occurring in patients with autism.

Neuroimmune Clinician Network Members are dedicated core members of the neuroimmune community who receive exclusive benefits, including access to:

  • Live discussions and Q&As with highly regarded experts in the field
  • Exclusive access to premium content, including recordings from CME events
  • Steep discounts for CME events, including the Inflammatory Brain Disorders Conference
  • Priority registration to events
  • Relevant new research compiled and emailed to you so you can stay up to date on new findings
  • Opportunities to provide feedback that will guide activities

Neuroimmune Institute:

  • Keeps members apprised of the latest research, treatment, and clinical advances.
  • Gives individuals the opportunity to come together, pool their knowledge and expertise, and work collaboratively toward common goals that address the lack of widespread access to care for patients with neuroimmune conditions.
  • Creates a sense of community amongst members, providing networking opportunities, collaboration, and knowledge sharing.

The majority of the content available has physician CME requirements in mind, however, all professionals listed are welcome to join:

* generalists – adult and pediatric

* pediatricians

* immunologists

* psychiatrists

* neurologists

* infectious disease specialists

* rheumatologists

* other specialists

* nurse practitioners

* physician assistants

* researchers

* therapists and social workers

* related healthcare professionals

  • Membership in the Neuroimmune Clinician Network is $19.99 per month.
  • Please view the full terms and conditions including conference discount details here.

Neuroimmune Clinician Network Members can highlight their commitment to staying apprised of the latest research, treatment, and clinical advances by placing this seal on their website.

 

Recordings currently accessible on demand to Neuroimmune Clinician Network members (updated regularly)

Single Lectures

 

Professor Russell Dale

Russell Dale, MBChB, PhD

Professor of Paediatric Neurology and Paediatric Neurology Research; Head, Kids Neuroscience Centre, Children’s Hospital at Westmead, Academic Leader (Research), Specialty of Child and Adolescent Health; Faculty of Medicine and Health, University of Sydney

Q&A – PANS/PANDAS, AE, seronegative encephalitis
Prof. Lauren Breithaupt Langston

Lauren Breithaupt Langston, PhD

Assistant Professor of Psychology in the Department of Psychiatry, Massachusetts General Hospital

From Immune Signals to Clinical Decisions:
Precision Care in PANDAS and Neuroimmune Psychiatry
Dr. Christopher Palmer

Christopher M. Palmer, MD

Assistant Professor of Psychiatry, Harvard Medical School; Founder and Director, Metabolic and Mental Health Program, Director, Department of Postgraduate and Continuing Education, McLean Hospital

The Ketogenic Diet: An Anti-Inflammatory and Immune-Modulating
Treatment for Neuropsychiatric Disorders
Prof. Stefano Pallanti

Stefano Pallanti, MD, PhD

Professor of Psychiatry, Albert Einstein College of Medicine; Professor of Psychiatry, Imperial College; Professor of Psychiatry, Icahn School of Medicine at Mount Sinai; Medical and Scientific Director of the Institute of Neuroscience, Italy

New Target for rTMS in OCD: Focus on Neuroinflammation

John Pluvinage, MD, PhD

Physician-scientist, Department of Neurology, UCSF

Autoimmune Vitamin B12 Central Deficiency
Dr. Antonios Kolios

Antonios Kolios, MD, PD

Senior Attending Physician, Department of Dermatology, Head of Immunodermatology Unit, University
Hospital Zurich

IL-2 and Tregs in the Therapy of Autoimmune and Inflammatory
Diseases
John Gaitanis

John Gaitanis, MD

Associate Professor of Pediatrics, Clinician Educator, Brown University School of Medicine; Director of Child Neurology, Brown Medical School; Pediatric Neurologist, Hasbro Children’s Hospital

Q&A – PANS/PANDAS (including in autism)
Doctor Mark Pasternak.

Mark Pasternack, MD

Chief of Pediatric Infectious Disease, Massachusetts General Hospital Associate Professor of Pediatrics, Massachusetts General Hospital, Harvard

Pediatric Acute-Onset Neuropsychiatric Syndrome from the Perspective of an Infectious Disease Physician
Dr. Ming Lim

Ming Lim, MD, PhD

Professor, Paediatric Neurology, King’s College London, HOS Children’s Neuroscience, Consultant Paediatric Neurologist, Children’s Neuroscience Centre, Evelina London Children’s Hospital, King’s Health Partners Academic Health Science Centre

Optimizing Treatment in Pediatric Neuroinflammation: How Quickly and How Much
Dr. Golam Khandaker

Golam Khandaker, MBBS, MPhil, PhD, FRCPsych

Professor of Psychiatry and Immunology, MRC Investigator; Head, Immunopsychiatry Programme, MRC Integrative Epidemiology Unit; Co-Lead, NIHR Bristol BRC Mental Health Theme, University of Bristol

Inflammation and Immunity in Depression: From Mechanism Toward New Therapeutics
Dr. Lael Yonker

Lael Yonker, MD

Associate Professor of Pediatrics, Harvard Medical School; Director, MGH Cystic Fibrosis Center; Principal Investigator, Pediatric COVID-19 Biorepository, Mucosal Immunology and Biology Research Center, Massachusetts General for Children

Diagnosing and Treating Long COVID in Children: Current Insights and Ongoing Challenges

Marion Leboyer, MD, PhD

Professor and Chair of the Department of Psychiatry & Addictology, University Paris-Est Créteil; Director, Translational Neuropsychiatry Lab; CEO, Fondation FondaMental

Immuno-Genetic Risk in Major Psychiatric Disorders

Terry Harville, MD, PhD

Professor of Pathology and Laboratory Services, and Internal Medicine, The University of Arkansas for Medical Sciences (UAMS); Medical Director, HLA and Histocompatibility Laboratory, UAMS

IVIG in PANS and Related Conditions
Professor Russell Dale

Russell Dale, MBChB, MRCP, PhD

Professor of Paediatric Neurology and Paediatric Neurology Research; Head, Kids Neuroscience Centre, Children’s Hospital at Westmead, Academic Leader (Research), Specialty of Child and Adolescent Health; Faculty of Medicine and Health, University of Sydney

Novel Biomarker Approaches in Neuroinflammation – The ‘Omic Era’
Dr. Ming Lim

Ming Lim, MD, PhD

Professor, Paediatric Neurology, King’s College London, HOS Children’s Neuroscience, Consultant Paediatric Neurologist, Children’s Neuroscience Centre, Evelina London Children’s Hospital

Atypical Presentations of Autoimmune Encephalitis
Doctor Andrew Baumel.

Andrew Baumel, MD

Pediatrician, Framingham Pediatrics

Treating PANS/PANDAS: A Pediatrician’s Perspective followed by Q&A
Dr. Jeffrey M. Gelfand

Jeffrey Gelfand, MD

Associate Professor of Neurology, Department of Neurology; UCSF

Practical Approaches When Using Immuno­suppressive Treatments Beyond Steroids and IVIg for Neuro­inflammatory Diseases
Dr. Belinda Lennox

Belinda Lennox, DM, FRCPsych

Professor and Head of Department of Psychiatry, University of Oxford

Immunotherapy in Autoimmune Psychiatric Illness

Richard P. Morse, MD

Chief, Child Neurology, Dartmouth Children’s Health; Professor of Pediatrics and Neurology, Geisel School of Medicine

PANS/PANDAS Cases: A Neurologist’s Perspective
Doctor Shannon Delaney.

Shannon Delaney, MD

Neuropsychiatrist, Private Practice, Formerly Assistant Professor of Psychiatry, Columbia University Medical Center; Director, Child and Adolescent Evaluation, Lyme & Tick-Borne Disease Research Center

Q&A – Neuropsychiatric Deteriorations in Tick-Borne Illnesses
Doctor Mark Pasternak.

Mark Pasternack, MD

Chief of Pediatric Infectious Disease, Massachusetts General Hospital Associate
Professor of Pediatrics, Massachusetts General Hospital, Harvard

Q&A – Infections and Use of Antibiotics in PANS/PANDAS
Doctor Richard Frye

Richard Frye, MD, PhD

President and Chief Scientific Officer, Autism Discovery and Treatment Foundation; Principal Investigator, Southwest Autism Research and Resource Center

Q&A – PANS/PANDAS, Autism, Metabolic/Mitochondrial Disorders, Leucovorin
Doctor Robert Yolken.

Robert Yolken, MD

Professor of Neurovirology in Pediatrics, Johns Hopkins University School of Medicine

Infections and Inflammation in Neuropsychiatric Illness: Focus on Food Antigens and Epstein Barr Virus

Laura Pace, MD, PhD, FACG

Clinical Assistant Professor, Medicine – Gastroenterology & Hepatology, Stanford University School of Medicine

The Neuroimmune Axis: Clinical Implications
Karen Parker PhD photo

Karen Parker, PhD

Professor, Department of Psychiatry & Behavioral Sciences; Principal Investigator, Social Neurosciences Research Program; Chair, Psychiatry Major Laboratories Steering Committee; Associate Chair, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine

Vasopressin: A Robust Biomarker and Promising Therapeutic for Autism
Harland Winter MD photo

Harland Winter, MD

Director, Center for Pediatric Inflammatory Bowel Disease, Massachusetts General Hospital for Children; Associate Professor, Harvard Medical School

The Role of the Gastro­intestinal Tract and the Microbiome in Individuals Who Are on the Autism Spectrum
Dr. Douglas Wallace

Douglas Wallace, MD, PhD

Michael and Charles Barnett Endowed Chair in Pediatric Mitochondrial Medicine and Metabolic Disease; Director, Center for Mitochondrial and Epigenomic Medicine, The Children’s Hospital of Philadelphia; Professor, Department of Pediatrics, Division of Human Genetics Perelman School of Medicine, University of Pennsylvania

A Mitochondrial Etiology of Autism and Associated Neuropsychiatric Disorders
Dr. Terry Harville

Terry Harville, MD, PhD

Professor of Pathology and Laboratory Services, and Internal Medicine; Medical Director, HLA and Histocompatibility Laboratory; Medical Director, Immunogenetics and Transplantation Laboratory; Medical Director UAMS ABG Laboratory, The University of Arkansas for Medical Sciences

Case Presentations of the Spectrum of ASD
Dr. John Gaitanis

John Gaitanis, MD

Associate Professor of Pediatrics, Clinician Educator, Brown University; Director of Child Neurology, Brown Medical School; Pediatric Neurologist, Hasbro Children’s Hospital

Autism, Epilepsy, and Aggression
Doctor Richard Frye

Richard Frye, MD, PhD

President and Chief Scientific Officer, Autism Discovery and Treatment Foundation; Director of Research, Rossignol Medical Center; Sponsor and Principal Investigator, Southwest Autism Research and Resource Center

Neurodevelopmental Regression: Causes, Workup, and Treatment
Ritika Kapoor

Ritika Kapoor, MBBS, PhD, FRCPCH

Consultant Paediatric Endocrinologist and Honorary Reader, King’s College Hospital, NHS Foundation Trust & King’s College, London

Neurobehavioural Impairments in Disorders of The Hypothalamo-Pituitary Axis
Dr. Ben Marlow

Ben Marlow, MBBS, MRCPCH, PGCME

Consultant Paediatrician (Neurodevelopment) ESNEFT; Clinical Director – The Synapse Centre for Neurodevelopment; Clinical Lead for Paediatrics SNEE ICB; Visiting Senior Lecturer Anglia Ruskin School of Medicine

Sleep Difficulties in Autism: Investigation and Management Strategies
Dr. Andrew Zimmerman

Andrew Zimmerman, MD

Professor of Pediatrics and Neurology (Retired), UMass Memorial Medical Center

Clinical Trials of Sulforaphane (SF) in Autism Spectrum Disorder (ASD): Efficacy and Biomarkers
Doctor Emily Severance

Emily Severance, PhD

Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine

Inflammation and The Gut-Brain Axis in Autism – Research Strides Point to Dietary Interventions
Dr. John Lukens

John Lukens, PhD

Associate Professor, Department of Neuroscience, University of Virginia

Role of Maternal Immune Activation and Serotonin Reuptake Inhibitors in Autism-Related Neuro­develop­mental Disorders
Dr. Melody Lun

Melody Lun, MD, PhD

Clinical Fellow, Neonatology; Postdoctoral Fellow, Pleasure-Wilson Labs, University of California – San Fransisco

Novel Autoantibody Discovery in Autism Spectrum Disorder
Doctor Naveen Nagarajan.

Naveen Nagarajan, PhD

Postdoctoral Associate, Dr. Mario Capecchi Lab, Eccles Institute of Human Genetics, University of Utah

Calcium Transients in Microglia Drive ASD/OCD-Like Repetitive and Anxiety Behaviors
Dr. Needham

Brittany Needham, PhD

Assistant Professor, Indiana School of Medicine

Modulation of the Gut Microbiome in ASD

Lectures with multiple speakers

Doctor Jennifer Frankovich

Jennifer Frankovich, MD, MS

Clinical Professor of Pediatrics, Rheumatology, Stanford University School of Medicine; Director, Stanford PANS Research Program

Doctor Meiqian Ma.

Meiqian Ma, MD

Clinical Assistant Professor, Pediatrics – Rheumatology Stanford University School of Medicine

Dr. Melissa Silverman

Melissa Silverman, MD

Clinical Assistant Professor, Psychiatry and Behavioral Sciences – Child and Adolescent Psychiatry and Child Development, Stanford University School of Medicine

Bahare Farhadian FNP

Bahare Farhadian, MSN, RN, FNP-C

Rheumatology – Family Nurse Practitioner, Stanford Medicine Children’s Health

Infection and Inflammation Related Neuropsychiatric Deteriorations in Youth with Autism: Case Presentations by The Stanford Immune Behavioral Health Team

Neuroimmune Research Updates

Curated recent research in neuroimmune and inflammatory brain disorders

  • Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions

    Nature | Molecular Psychiatry
    April 25, 2025

  • New-onset OCD and juvenile enthesitis related arthritis after COVID-19 (Three Cases)

    Karger Developmental Neuroscience
    April 2, 2025

  • Naproxen Adjunct to Fluoxetine for Moderate-to-severe Obsessive-compulsive Disorder: A Randomized, Double-blind, Placebo-controlled Trial

    Psychiatry and Clinical Neurosciences / Wiley
    October 1, 2024

Cancel Membership

Assuming you have fulfilled the terms and conditions (please note that you agreed prior to purchase of your membership to a 12 month subscription in three places on the check out screen), your cancellation will be processed right away. If you have not yet fulfilled the terms and conditions, your cancellation will be processed after your final payment. Please be sure to enter the email address you registered your membership under as well as your correct name.

"*" indicates required fields

Name*